Recombinant Factor VIIa in Acute Intracerebral Haemorrhage
Public ClinicalTrials.gov record NCT00127283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral Haemorrhage
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in Asia, Europe, Middle East, North America, Oceania, and South America. The purpose of this study is to evaluate the treatment of Recombinant Factor VIIa (eptacog alfa (activated)) in patients with acute intracerebral bleeding. It is expected that more patients will recover without severe permanent disability after acute treatment with Recombinant Factor VIIa by reducing further intracerebral bleeding.
Study identification
- NCT ID
- NCT00127283
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 829 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2005 (Type not available)
- Primary completion
- Jan 2007 (Actual)
- Completion
- Jan 2007 (Actual)
- Last update posted
- Jan 12, 2017
2005 – 2007
United States locations
- U.S. sites
- 77
- U.S. states
- 35
- U.S. cities
- 68
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Birmingham | Alabama | 35209 | — |
| Novo Nordisk Investigational Site | Mobile | Alabama | 36617 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85013 | — |
| Novo Nordisk Investigational Site | Fort Smith | Arkansas | 72901 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90024 | — |
| Novo Nordisk Investigational Site | Oceanside | California | 92056 | — |
| Novo Nordisk Investigational Site | Orange | California | 92868-4280 | — |
| Novo Nordisk Investigational Site | Sacramento | California | 95816 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92103 | — |
| Novo Nordisk Investigational Site | San Francisco | California | 94110-3594 | — |
| Novo Nordisk Investigational Site | San Francisco | California | 94143-0780 | — |
| Novo Nordisk Investigational Site | Stanford | California | 94305 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80204 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80262 | — |
| Novo Nordisk Investigational Site | Englewood | Colorado | 80113 | — |
| Novo Nordisk Investigational Site | Hartford | Connecticut | 06102 | — |
| Novo Nordisk Investigational Site | Washington D.C. | District of Columbia | 20010 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32209 | — |
| Novo Nordisk Investigational Site | Melbourne | Florida | 32901 | — |
| Novo Nordisk Investigational Site | Tallahassee | Florida | 32308 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33606 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30320 | — |
| Novo Nordisk Investigational Site | Augusta | Georgia | 30912-3260 | — |
| Novo Nordisk Investigational Site | Decatur | Georgia | 33033 | — |
| Novo Nordisk Investigational Site | Honolulu | Hawaii | 96813 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60611 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60612 | — |
| Novo Nordisk Investigational Site | Maywood | Illinois | 60153 | — |
| Novo Nordisk Investigational Site | Peoria | Illinois | 61637 | — |
| Novo Nordisk Investigational Site | Fort Wayne | Indiana | 46805 | — |
| Novo Nordisk Investigational Site | Indianapolis | Indiana | 46260 | — |
| Novo Nordisk Investigational Site | Iowa City | Iowa | 52242 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40536 | — |
| Novo Nordisk Investigational Site | Louisville | Kentucky | 40202 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21287 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02118 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02144 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02215 | — |
| Novo Nordisk Investigational Site | Detroit | Michigan | 48201 | — |
| Novo Nordisk Investigational Site | Golden Valley | Minnesota | 55422 | — |
| Novo Nordisk Investigational Site | Blackwater | Mississippi | 39216 | — |
| Novo Nordisk Investigational Site | Kansas City | Missouri | 64111 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63110-1010 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63110 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89109 | — |
| Novo Nordisk Investigational Site | Lebanon | New Hampshire | 03756-0001 | — |
| Novo Nordisk Investigational Site | Cherry Hill | New Jersey | 08034 | — |
| Novo Nordisk Investigational Site | Hackensack | New Jersey | 07465 | — |
| Novo Nordisk Investigational Site | Ridgewood | New Jersey | 07450 | — |
| Novo Nordisk Investigational Site | Buffalo | New York | 14215 | — |
| Novo Nordisk Investigational Site | New York | New York | 10032 | — |
| Novo Nordisk Investigational Site | Stony Brook | New York | 11794-8121 | — |
| Novo Nordisk Investigational Site | Chapel Hill | North Carolina | 27599-7025 | — |
| Novo Nordisk Investigational Site | Charlotte | North Carolina | 28232-2861 | — |
| Novo Nordisk Investigational Site | Durham | North Carolina | 27705 | — |
| Novo Nordisk Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45267 | — |
| Novo Nordisk Investigational Site | Cleveland | Ohio | 44195 | — |
| Novo Nordisk Investigational Site | Portland | Oregon | 97225 | — |
| Novo Nordisk Investigational Site | Portland | Oregon | 97239 | — |
| Novo Nordisk Investigational Site | Allentown | Pennsylvania | 18103-6208 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | 15212-4746 | — |
| Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | 15213-2546 | — |
| Novo Nordisk Investigational Site | Charleston | South Carolina | 29425 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37403 | — |
| Novo Nordisk Investigational Site | Hashville | Tennessee | 37232 | — |
| Novo Nordisk Investigational Site | Memphis | Tennessee | 38163 | — |
| Novo Nordisk Investigational Site | Nashville | Tennessee | 37205 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75390-8897 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77030 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | Burlington | Vermont | 05401 | — |
| Novo Nordisk Investigational Site | Charlottesville | Virginia | 22908 | — |
| Novo Nordisk Investigational Site | Seattle | Washington | 98102 | — |
| Novo Nordisk Investigational Site | Madison | Wisconsin | 53792-3236 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00127283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2017 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00127283 live on ClinicalTrials.gov.